Neuro-Oncology

Published by: Oxford University Press  

People

  1. Kramer
    Kramer
  2. Cheung
    Cheung
  3. Zanzonico
    Zanzonico
  4. Humm
    Humm
  5. Souweidane
    Souweidane
  6. Carrasquillo
    Carrasquillo
  7. Dunkel
    Dunkel
  8. Haque
    Haque
  9. Khakoo
    Khakoo
  10. Lyashchenko
    Lyashchenko

Groups

  1. Sloan Kettering Institute Faculty (48)
  2. GSK Faculty (47)
  3. Center for Molecular Imaging and Biotechnology (CMIB) (33)
  4. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (27)
  5. Molecular Pharmacology and Chemistry Program Faculty (26)
  6. Tow Center for Developmental Oncology (TCDO) (23)
  7. Sloan Kettering Institute Postdocs (20)
  8. Cancer Biology and Genetics Program Faculty (17)
  9. Radiology, Department of (16)
  10. Molecular Imaging and Therapy Service (15)
Search Within
  1. "Sloan Kettering Institute Faculty"
Formats
  1. Meeting Abstract (42)
  2. Journal Article (5)
  3. Editorial (1)
Groups
  1. Sloan Kettering Institute Faculty (48)
  2. GSK Faculty (47)
  3. Center for Molecular Imaging and Biotechnology (CMIB) (33)
  4. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (27)
  5. Molecular Pharmacology and Chemistry Program Faculty (26)
  6. Tow Center for Developmental Oncology (TCDO) (23)

More Groups

People
  1. Steven Larson (14)
  2. Kim Kramer (12)
  3. Nai-Kong Cheung (11)
  4. Pat Zanzonico (11)
  5. Neeta Pandit-Taskar (10)
  6. John Humm (9)

More People

Years
  1. 2025 (1)
  2. 2024 (1)
  3. 2023 (1)
  4. 2022 (2)
  5. 2021 (2)
  6. 2020 (2)

More Years

Publishers
  1. Oxford University Press (48)

Results (48)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase 1 dose-escalation trial using convection-enhanced delivery of radio-immunotheranostic 124I-Omburtamab for diffuse intrinsic pontine glioma
    Journal Article

    Souweidane, M. M.; Bander, E. D.; Zanzonico, P.; Reiner, A. S.; Manino, N.; Haque, S.; Carrasquillo, J. A.; Lyashchenko, S. K.; Thakur, S. B.; Lewis, J. S.; more...
    Neuro-Oncology (2025)

    Fulltext@MSK | Save
  • Enhancement of blood-brain barrier penetration and tumor targeted drug delivery for DMG using a P-selectin targeted nanomedicine approach
    Meeting Abstract

    Li, B. K.; Vaynshteyn, J.; Tylawsky, D.; Vogt, K.; Raziuddin, R.; Ge, Y.; Heller, D. A.; Becher, O.; Raju, G. P.
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Loss of micrornas cooperates with tumor suppressors to initiate MYC-dependent metastatic medulloblastoma
    Meeting Abstract

    Llaguno, S. A.; Nazarenko, I.; Chen, Y.; Sun, D.; Gudenas, B.; Saulnier, O.; La Rocca, G.; Pedraza, A.; Burns, D.; Bale, T.; more...
    Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • A novel epigenetic nanotherapeutic strategy to induce medulloblastoma differentiation
    Meeting Abstract

    Raju, P.; Tylawsky, D.; Vaynshteyn, J.; Gerwin, J.; Heller, D.; Snuderl, M.
    Neuro-Oncology (2022)

    Fulltext@MSK | Save
  • Long-term survival from a phase 1 doseescalation trial using convection-enhanced delivery (CED) of radioimmunotherapeutic (124)I-omburtamab for treatment of diffuse intrinsic pontine glioma (DIPG)
    Meeting Abstract

    Souweidane, M. M.; Kramer, K.; Pandit-Tasker, N.; Haque, S.; Zanzonico, P.; Carrasquillo, J.; Lyashchenko, S. K.; Thakur, S. B.; Khakoo, Y.; Dunkel, I. J.; more...
    Neuro-Oncology (2022)

    Fulltext@MSK | Save
  • Loss of dicer cooperates with tumor suppressors to initiate metastatic medulloblastoma
    Meeting Abstract

    Llaguno, S. A.; Nazarenko, I.; Chen, Y.; Sun, D.; La Rocca, G.; Pedraza, A.; Gudenas, B.; Saulnier, O.; Burns, D.; Bale, T.; more...
    Neuro-Oncology (2021)

    Fulltext@MSK | Save
  • Unique challenges for glioblastoma immunotherapy - discussions across neuro-oncology and non-neuro-oncology experts in cancer immunology. Meeting report from the 2019 SNO Immuno-Oncology Think Tank
    Editorial

    Chuntova, P.; Chow, F.; Watchmaker, P. B.; Galvez, M.; Heimberger, A. B.; Newell, E. W.; Diaz, A.; DePinho, R. A.; Li, M. O.; Wherry, E. J.; more...
    Neuro-Oncology (2021)

    Fulltext@MSK | Save
  • Nanotherapeutic targeting of tumor endothelium for enhancing drug delivery past the blood-brain barrier
    Meeting Abstract

    Kiguchi, H.; Tylawsky, D.; Vaynshteyn, J.; Gerwin, J.; Manzari, M.; Shah, J.; Li, N.; Shamay, Y.; Greenblatt, M.; Heller, D.; more...
    Neuro-Oncology (2020)

    Fulltext@MSK | Save
  • Decoding the immune system response to leptomeningeal metastasis
    Meeting Abstract

    Remsik, J.; Tong, X.; Sener, U.; Isakov, D.; Chi, Y.; Iacobuzio-Donahue, C.; Pe'er, D.; Schietinger, A.; Boire, A.
    Neuro-Oncology (2020)

    Fulltext@MSK | Save
  • Somatic mutations of chromatin regulator Kmt2d in cerebellar precursors influences SHH-medulloblastoma tumorigenesis
    Meeting Abstract

    Sanghrajka, R.; Tan, I. L.; Wojcinski, A.; Rallapalli, H.; Turnbull, D.; Ge, K.; Joyner, A.
    Neuro-Oncology (2019)

    Fulltext@MSK | Save

    • Neuro-Oncology – authorized name for:

    Name ISSN / ISBN Publisher
    Neuro-Oncology 1523-5866 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1523-5866 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1523-5866 Oxford University Press
    Neuro-oncology 1523-5866 Oxford University Press
    Neuro-Oncology 1523-5866 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press On Behalf of the Society for Neuro Oncology
    Neuro-Oncology 1523-5866 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1523-5866 Oxford University Press
    Neuro-oncology 15235866 Unknown
    Neuro-Oncology 15228517 The Author(s) 2024
    Neuro-Oncology 1523-5866 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 15228517 The Author(s)
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 15228517 Oxford University Press On Behalf of the Society for Neuro Oncology
    Neuro-Oncology 1522-8517 Carden Jennings Publ Co Ltd
    Neuro-Oncology 1522-8517 Duke University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 15228517 Unknown
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 15228517 The Author(s) 2023
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-oncology 1523-5866 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1523-5866 Oxford University Press
    Neuro-Oncology 1523-5866 Oxford University Press
    Neuro-oncology 15235866 Oxford University Press On Behalf of the Society for Neuro Oncology
    Neuro-Oncology 1522-8517 Duke University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1523-5866 Oxford University Press On Behalf of the Society for Neuro Oncology
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 15235866 Elsevier B.V.
    Neuro-Oncology 1522-8517 Society for Neuro Oncology